Clinical trials referenced in this document:
Documents that mention this clinical trial
Evaluation of the impact of renal impairment on the pharmacokinetics of glasdegib in otherwise healthy volunteers
https://doi.org/10.1007/s00280-020-04207-9
Article History
Received: 15 September 2020
Accepted: 19 November 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: Drs N. Shaik, R. LaBadie, B. Hee, and G. Chan were employees of Pfizer during this study.
: The study protocol was approved by an independent institutional review board at each investigational center and was conducted in accordance with the 1964 Declaration of Helsinki and Good Clinical Practice guidelines.
: Informed consent was obtained from all individual participants included in the study.